Workshop on Clinical Doctorate Program Regulations at Faculty of Medicine, Sana’a University Eyl 08, 2025 Beatriz Escanilla Healthcare
U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease Eyl 06, 2025 System Admin Healthcare
W. Equatoria, partners launch 5-year health master plan in Yambio Eyl 04, 2025 Beatriz Escanilla Healthcare
Libya and Italy discuss further health cooperation including, doctors exchange, training, hospital twinning and pharma manufacturing Eyl 04, 2025 Beatriz Escanilla Healthcare
MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline Eyl 04, 2025 System Admin Healthcare
Sidra, QIIB partner to enhance healthcare services in Qatar- Eyl 03, 2025 Beatriz Escanilla Healthcare
شركتا Polpharma Biologics وMS Pharma توقعان اتفاقيات ترخيص لتطوير البدائل الحيوية المقترحة Vedolizumab (PB016) وOcrelizumab (PB018) وGuselkumab (PB019) Eyl 03, 2025 System Admin Healthcare
Pharmaceutical industry: several agreements expected at IATF-2025 in Algiers Eyl 03, 2025 Beatriz Escanilla Healthcare
